Cargando...
Risk‐reducing medications for primary breast cancer: a network meta‐analysis
BACKGROUND: Breast cancer is the most frequently occurring malignancy and the second cause of death for cancer in women. Cancer prevention agents (CPAs) are a promising approach to reduce the burden of breast cancer. Currently, two main types of CPAs are available: selective estrogen receptor modula...
Guardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2019
|
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487387/ https://ncbi.nlm.nih.gov/pubmed/31032883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012191.pub2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|